Literature DB >> 15002890

Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.

Renata Górska1, Hanna Gregorek, Jan Kowalski, Agnieszka Laskus-Perendyk, Małgorzata Syczewska, Kazimierz Madaliński.   

Abstract

OBJECTIVE: The purpose of the present study was to assess the relation between clinical parameters and concentrations of the key (IL-1beta, TNF-alpha, IL-2, IFN-gamma, IL-4, IL-10) cytokines, important in the initiation and progression of periodontal diseases, within inflamed gingival tissues and serum samples from patients with severe chronic periodontitis.
MATERIAL AND METHODS: Twenty-five patients with severe chronic periodontitis, who had sites with probing depths (PD) > 5 mm, and 25 periodontally healthy persons were included in the study. Clinical examinations including PD, clinical attachment loss, plaque index, and bleeding index were performed before periodontal treatment. Gingival tissue biopsies were collected from one active site of each patient and from healthy individuals, and blood samples were withdrawn on the day of tissue biopsy. The concentrations of cytokines were determined by an enzyme-linked immunosorbent assay, and the relationship between their profiles in situ and in circulation with clinical parameters was analysed.
RESULTS: The concentrations of IL-1beta, TNF-alpha, IL-2, IFN-gamma were, on average, significantly higher in serum samples and gingival tissue biopsies from periodontitis patients than in healthy controls. However, serum samples from both groups showed high individual variability of cytokine profiles, and no association between cytokine concentrations and clinical parameters of periodontitis was found. On the contrary, the levels of IL-4 and IL-10 in both kinds of samples obtained from patients and controls were generally low or even undetectable, and remained, on average, on the same level. However, the frequency of IL-4 (88% positive samples) and IL-10 (72%) was much higher in healthy gingival tissues. High concentrations of TNF-alpha, IFN-gamma and IL-2 and, especially, a high ratio of IL-1beta/IL-10 and TNF-alpha/IL-4 found in tissue biopsies from periodontitis patients, strongly correlated with the severity of periodontitis.
CONCLUSION: These results indicate that high variability of cytokine concentrations and low frequency of their detection in serum samples from periodontitis patients make these determinations useless for the detection of disease presence and/or its severity. In contrast, high absolute levels of IL-1beta, TNF-alpha, IL-2 and IFN-gamma and, especially their high ratios to IL-4 and IL-10 found in inflamed tissue biopsies, were closely associated with periodontal disease severity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15002890     DOI: 10.1046/j.0303-6979.2003.00425.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  79 in total

Review 1.  Periodontitis: a polymicrobial disruption of host homeostasis.

Authors:  Richard P Darveau
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

2.  Full-mouth ultrasonic debridement associated with povidone iodine rinsing in GAgP treatment: a randomised clinical trial.

Authors:  Hugo Felipe do Vale; Renato Corrêa Viana Casarin; Tiago Taiete; Gláucia Maria Bovi Ambrosano; Karina Gonzales Silvério Ruiz; Francisco Humberto Nociti; Enílson Antônio Sallum; Márcio Zaffalon Casati
Journal:  Clin Oral Investig       Date:  2015-04-16       Impact factor: 3.573

Review 3.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

4.  Systemic Immunologic Consequences of Chronic Periodontitis.

Authors:  D K Gaudilliere; A Culos; K Djebali; A S Tsai; E A Ganio; W M Choi; X Han; A Maghaireh; B Choisy; Q Baca; J F Einhaus; J J Hedou; B Bertrand; K Ando; R Fallahzadeh; M S Ghaemi; R Okada; N Stanley; A Tanada; M Tingle; T Alpagot; J A Helms; M S Angst; N Aghaeepour; B Gaudilliere
Journal:  J Dent Res       Date:  2019-06-21       Impact factor: 6.116

5.  Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.

Authors:  M H Napimoga; E P Rocha; C A Trindade-da-Silva; A P D Demasi; E F Martinez; C G Macedo; H B Abdalla; A Bettaieb; F G Haj; J T Clemente-Napimoga; B Inceoglu; B D Hammock
Journal:  J Periodontal Res       Date:  2018-05-31       Impact factor: 4.419

6.  [Correlation between interleukin-10 polymorphisms and susceptibility to chronic periodontitis among Uygur adults in the Moyu area].

Authors:  Zhang Yuhui; Huang Ping; Lin Jing; Zhao Jin
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-10-01

7.  Effect of periodontal treatment on peak serum levels of inflammatory markers.

Authors:  Adnan Ali Almaghlouth; Norbert Cionca; José Antonio Cancela; Fabien Décaillet; Delphine S Courvoisier; Catherine Giannopoulou; Andrea Mombelli
Journal:  Clin Oral Investig       Date:  2014-01-23       Impact factor: 3.573

8.  Tissue destruction induced by Porphyromonas gingivalis infection in a mouse chamber model is associated with host tumor necrosis factor generation.

Authors:  Yuh-Yih Lin; Jan-Hung Huang; Yo-Yin Lai; Han-Ching Huang; Suh-Woan Hu
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

9.  The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus.

Authors:  Dong-Seok Shin; Jin-Woo Park; Jo-Young Suh; Jae-Mok Lee
Journal:  J Periodontal Implant Sci       Date:  2010-02-28       Impact factor: 2.614

10.  Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes.

Authors:  Andrea A Kalus; L Page Fredericks; Beth M Hacker; Henrik Dommisch; Richard B Presland; Janet R Kimball; Beverly A Dale
Journal:  BMC Oral Health       Date:  2009-08-27       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.